-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology IC50 Platform: An Innovative Force for Drug Discovery and Life Science Research
Author:
InnoModels
Release time:
2024-10-15
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Core advantages of IC50 platform
1、Professional team and rich experience
InnoModels Biotechnology has a professional team with more than 15 years of experience in IC50 and cell culture. These lab technicians not only specialize in IC50 assay and cell culture technology, but also have accumulated rich knowledge and experience in the field of cell activity detection. Their professional background and rigorous attitude ensure the accuracy and reliability of every experimental result.
2、Abundant cell resources
The platform has more than 400 human-derived tumor cell lines, covering a wide range of cancer types and subtypes. This comprehensive cell bank resource enables researchers to easily select cell lines suitable for their research needs, whether for anti-cancer drug screening or mechanism research.
3、Strict quality control
InnoModels Biotechnology attaches great importance to the quality of data and the safety of experiments. All cells are tested for STR (Short Tandem Repeat Sequence) before use to ensure the accuracy of cell identity. In addition, the platform regularly tests for mycoplasma and chlamydia in the cell culture solution to ensure the reliability and safety of the experiments. This strict quality control system provides researchers with reliable data assurance.

Technical applications of IC50 platform
1、Drug R&D
In the field of drug discovery and development, the IC50 platform helps researchers evaluate the inhibitory effect of potential drug candidates by accurately measuring the half-maximal effect concentration (IC50 value) of a drug on cell growth inhibition. This technology not only optimizes the drug design and development process, but also improves the success rate of new drug development.
2. Life science research
In life science research, the determination of IC50 values is important for in-depth understanding of the functions and interactions of biomolecules. By providing reliable IC50 value data, the IC50 platform of InnoModels provides researchers with an important research tool. The platform is also widely used in the field of toxicology research to assess the toxicity of compounds in living organisms.
Looking into the future
With the continuous progress of science and technology and the in-depth development of life science, InnoModels Biotechnology will continue to utilize the advantages of its IC50 platform to provide researchers with more efficient and reliable experimental solutions. At the same time, the company will continue to innovate and optimize its technology platform to meet the growing needs of scientific research.
In conclusion, with its core advantages such as professional team, abundant resources, strict quality control and wide range of application areas, the IC50 platform of InnoModels Biotechnology is gradually becoming an important force in promoting drug discovery and life science innovation. In the future development, we have reason to believe that the platform will continue to play an important role and contribute more wisdom and strength to the scientific research.
Previous Page
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd